DPP4 inhibitors as a potential therapeutic option for sarcopenia: A 6-month follow-up study in diabetic older patients.

Sencan, Canberk; Dost, Fatma Sena; Ates Bulut, Esra; Isik, Ahmet Turan

Sencan, Canberk; Dost, Fatma Sena; Ates Bulut, Esra; Isik, Ahmet Turan.

Affiliation

Sencan C; Department of Internal Medicine, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
Dost FS; Department of Geriatric Medicine, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey; Geriatric Sciences Association, Izmir, Turkey.
Ates Bulut E; Geriatric Sciences Association, Izmir, Turkey; Department of Geriatric Medicine, Adana State Hospital, Adana, Turkey.
Isik AT; Department of Geriatric Medicine, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey; Geriatric Sciences Association, Izmir, Turkey; Alzheimer Foundation, Turkey; Department of Neuroscience, Institute of Health Science, Dokuz Eylul University, Izmir, Turkey. Electronic address: atisik@yahoo.

Exp Gerontol ; 164: 111832, 2022 07.

Article in En | MEDLINE | ID: mdl-35526704

Subject(s)
Key words

DPP4 inhibitors; Diabetes mellitus; Muscle mass; Muscle strength; Older adults; Sarcopenia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dipeptidyl Peptidase 4 / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sarcopenia Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Exp Gerontol Year: 2022 Document type: Article Affiliation country: Turquía Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google